Havana, June 22, 2021 (TDI): BioCubaFarma announced that the homegrown Abdala Vaccine has shown 92 percent efficacy. Cuba is currently working on nearly five different vaccines and begin immunizing its population for clinical trials. This important announcement came after the government said that another vaccine Soberana 2 has also proved to have 62 percent effective against the deadly COVID-19. It is important to note that WHO has set a 50 percent efficacy threshold for the COVID-19 related vaccines produced by different countries around the world. Cuba is currently working on five different vaccines to fight the COVID-19 pandemic at home.
On this announcement, President of Cuba Miguel Diaz-Canel shared his jubilation over the important news. Like all countries of the world, Cuba is also hit hard by the virus however there is a quick recovery phase. Cuba has strong health systems and expert doctors are globally recognized. As a result of the US sanctions, Cuban pharma has built its own better and latest vaccines over all these years. Cuba will be the first country in Latin America to produce its ow first COVID-19 vaccine
The Diplomatic Insight is a digital and print magazine focusing on diplomacy, defense, and development publishing since 2009.
